{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T05:03:20Z","timestamp":1777439000291,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007289","name":"Nanjing Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.bbrc.2018.05.108","type":"journal-article","created":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T21:35:41Z","timestamp":1527111341000},"page":"1060-1067","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["microRNA-608 inhibits human hepatocellular carcinoma cell proliferation via targeting the BET family protein BRD4"],"prefix":"10.1016","volume":"501","author":[{"given":"Ling","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dijuan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-Hu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengming","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lian-Bao","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2018.05.108_bib1","first-page":"5737","article-title":"Molecular targeted therapies in hepatocellular carcinoma: past, present and future","volume":"35","author":"Stotz","year":"2015","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbrc.2018.05.108_bib2","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/hepr.12459","article-title":"New molecularly targeted therapies against advanced hepatocellular carcinoma: from molecular pathogenesis to clinical trials and future directions","volume":"45","author":"Chuma","year":"2015","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.bbrc.2018.05.108_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrgastro.2013.143","article-title":"Chemopreventive strategies in hepatocellular carcinoma","volume":"11","author":"Singh","year":"2014","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrc.2018.05.108_bib4","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nrgastro.2010.100","article-title":"Hepatocellular carcinoma: a global view","volume":"7","author":"Yang","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrc.2018.05.108_bib5","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrc1934","article-title":"Hepatocellular carcinoma pathogenesis: from genes to environment","volume":"6","author":"Farazi","year":"2006","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.bbrc.2018.05.108_bib6","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.molcel.2014.05.016","article-title":"The mechanisms behind the therapeutic activity of BET bromodomain inhibition","volume":"54","author":"Shi","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbrc.2018.05.108_bib7","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.18632\/oncotarget.3551","article-title":"Inhibition of BET bromodomains as a therapeutic strategy for cancer drug discovery","volume":"6","author":"Fu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2018.05.108_bib8","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.virusres.2016.12.006","article-title":"Involvement of Brd4 in different steps of the papillomavirus life cycle","volume":"231","author":"Iftner","year":"2017","journal-title":"Virus Res."},{"key":"10.1016\/j.bbrc.2018.05.108_bib9","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1089\/jir.2015.0179","article-title":"Chromatin landscape of the IRF genes and role of the epigenetic reader BRD4","volume":"36","author":"Bachu","year":"2016","journal-title":"J.\u00a0Interferon Cytokine Res."},{"key":"10.1016\/j.bbrc.2018.05.108_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4161\/trns.22542","article-title":"Two faces of brd4: mitotic bookmark and transcriptional lynchpin","volume":"4","author":"Devaiah","year":"2013","journal-title":"Transcription"},{"key":"10.1016\/j.bbrc.2018.05.108_bib11","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature10334","article-title":"RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia","volume":"478","author":"Zuber","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2018.05.108_bib12","first-page":"232870","article-title":"Brd4 and HEXIM1: multiple roles in P-TEFb regulation and cancer","volume":"2014","author":"Chen","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.bbrc.2018.05.108_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines6010016","article-title":"BET family protein BRD4: an emerging actor in NFkappaB signaling in inflammation and cancer","volume":"6","author":"Hajmirza","year":"2018","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbrc.2018.05.108_bib14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/0394632015572070","article-title":"BRD4 promotes tumor growth and epithelial-mesenchymal transition in hepatocellular carcinoma","volume":"28","author":"Zhang","year":"2015","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.bbrc.2018.05.108_bib15","doi-asserted-by":"crossref","first-page":"32628","DOI":"10.18632\/oncotarget.8701","article-title":"Epigenetic reader BRD4 inhibition as a therapeutic strategy to suppress E2F2-cell cycle regulation circuit in liver cancer","volume":"7","author":"Hong","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2018.05.108_bib16","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1158\/1535-7163.MCT-15-0976","article-title":"Single agent and synergistic activity of the \"First-in-Class\" dual PI3K\/brd4 inhibitor SF1126 with sorafenib in hepatocellular carcinoma","volume":"15","author":"Singh","year":"2016","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.bbrc.2018.05.108_bib17","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrg.2016.20","article-title":"Endogenous microRNA sponges: evidence and controversy","volume":"17","author":"Thomson","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbrc.2018.05.108_bib18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nrg3965","article-title":"Towards a molecular understanding of microRNA-mediated gene silencing","volume":"16","author":"Jonas","year":"2015","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbrc.2018.05.108_bib19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nrg3162","article-title":"MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship","volume":"13","author":"Pasquinelli","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbrc.2018.05.108_bib20","doi-asserted-by":"crossref","first-page":"11039","DOI":"10.1007\/s13277-015-4598-1","article-title":"C6 ceramide sensitizes the anti-hepatocellular carcinoma (HCC) activity by AZD-8055, a novel mTORC1\/2 dual inhibitor","volume":"37","author":"Liu","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.bbrc.2018.05.108_bib21","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12943-017-0664-1","article-title":"MicroRNA-608 inhibits proliferation of bladder cancer via AKT\/FOXO3a signaling pathway","volume":"16","author":"Liang","year":"2017","journal-title":"Mol. Canc."},{"key":"10.1016\/j.bbrc.2018.05.108_bib22","article-title":"microRNA-200a downregulation in human glioma leads to G\u03b1i1 over-expression, Akt activation and cell proliferation","author":"Liu","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2018.05.108_bib23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cellsig.2017.10.010","article-title":"Bromodomain protein BRD4 promotes cell proliferation in skin squamous cell carcinoma","volume":"42","author":"Xiang","year":"2018","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbrc.2018.05.108_bib24","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.celrep.2015.04.063","article-title":"Co-activation of AMPK and mTORC1 induces cytotoxicity in acute myeloid leukemia","volume":"11","author":"Sujobert","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbrc.2018.05.108_bib25","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.canlet.2014.11.012","article-title":"Pre-clinical evaluation of AZD-2014, a novel mTORC1\/2 dual inhibitor, against renal cell carcinoma","volume":"357","author":"Zheng","year":"2015","journal-title":"Canc. Lett."},{"key":"10.1016\/j.bbrc.2018.05.108_bib26","doi-asserted-by":"crossref","first-page":"17698","DOI":"10.18632\/oncotarget.4131","article-title":"BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells","volume":"6","author":"Coude","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2018.05.108_bib27","doi-asserted-by":"crossref","first-page":"34669","DOI":"10.18632\/oncotarget.5785","article-title":"The BET bromodomain inhibitor, JQ1, facilitates c-FLIP degradation and enhances TRAIL-induced apoptosis independent of BRD4 and c-Myc inhibition","volume":"6","author":"Yao","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2018.05.108_bib28","first-page":"170","article-title":"HOXD-AS1 promotes cell proliferation, migration and invasion through miR-608\/FZD4 axis in ovarian cancer","volume":"8","author":"Wang","year":"2018","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.bbrc.2018.05.108_bib29","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.3892\/ijo.2017.4174","article-title":"miR-608 regulates apoptosis in human lung adenocarcinoma via regulation of AKT2","volume":"51","author":"Othman","year":"2017","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbrc.2018.05.108_bib30","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.18632\/oncotarget.6275","article-title":"Suppression of BRD4 inhibits human hepatocellular carcinoma by repressing MYC and enhancing BIM expression","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2018.05.108_bib31","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.3892\/ol.2015.3570","article-title":"BRD4 induces cell migration and invasion in HCC cells through MMP-2 and MMP-9 activation mediated by the Sonic hedgehog signaling pathway","volume":"10","author":"Wang","year":"2015","journal-title":"Oncol Lett"},{"key":"10.1016\/j.bbrc.2018.05.108_bib32","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.3892\/ol.2015.3759","article-title":"Function and clinical potential of microRNAs in hepatocellular carcinoma","volume":"10","author":"Wang","year":"2015","journal-title":"Oncol Lett"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18311719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18311719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:32:40Z","timestamp":1762093960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X18311719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0006291X18311719"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.05.108","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"microRNA-608 inhibits human hepatocellular carcinoma cell proliferation via targeting the BET family protein BRD4","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.05.108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}